BB
Blake Borgeson (Director) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales, 1 filed past the two-business-day deadline), most often in Recursion Pharmaceuticals, Inc. (RXRX). The largest single filing was $961K of RXRX (220,000 sh × $4.37, as filed), executed Dec 2 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
10
0 buys · 10 sells · 1 late
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.3M
shares × price, as filed
Last traded
Nov 3
Filed Nov 4
Median ADV $67.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $4.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
10 filings
Sector per market data · by filing · past 12 months
Most traded names
RXRXRecent filings
RXRXSALE
Recursion Pharmaceuticals, Inc.
View filing →
$155K40,000 sh × $3.88
Exec Nov 3
Filed Nov 4 · 5:12 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $242K
50,000 sh × $4.84
Exec Oct 6
Filed Oct 7 · 6:08 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $100K
30,000 sh × $3.34
Exec Sep 1
Filed Sep 2 · 6:01 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $158K
40,000 sh × $3.96
Exec Jul 7
Filed Jul 9 · 6:04 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $110K
30,000 sh × $3.68
Exec Jun 2
Filed Jun 4 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $106K
30,000 sh × $3.52
Exec May 5
Filed May 7 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $588K
170,000 sh × $3.46
Exec Mar 3
Filed Mar 4 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $924K
220,000 sh × $4.20
Exec Feb 3
Filed Feb 6 · 5:30 PM ET † More filings →